Literature DB >> 17578774

Risk factor analysis of permanent pacemaker infection.

Muhammad R Sohail1, Daniel Z Uslan, Akbar H Khan, Paul A Friedman, David L Hayes, Walter R Wilson, James M Steckelberg, Sarah M Stoner, Larry M Baddour.   

Abstract

Background. Several host- and procedure-related factors have been reported to increase the risk of permanent pacemaker (PPM) infection on the basis of descriptive analyses of case series. The purpose of this study is to assess the risk factors for PPM infection using case-control study methods.Methods. All patients who had a PPM implanted at our institution from January 1991 to December 2003 were retrospectively reviewed. Each patient who experienced a PPM infection was matched with 2 control subjects by age, sex, year of implantation, and duration of follow-up. Univariate and multivariable analyses were performed to identify significant risk factors for PPM infection.Results. Twenty-nine case patients and 58 control subjects met inclusion criteria. The majority (83%) of case patients presented with a pocket infection; a minority (10%) had PPM-related endocarditis. Staphylococcus species (69%) were the most common pathogens. On univariate analysis, previous PPM infection, malignancy, long-term corticosteroid use, multiple device revisions, a permanent central venous catheter, the presence of >2 pacing leads, and a lack of antibiotic prophylaxis at the time of PPM placement were associated with an increased risk of PPM infection. A multivariable logistic regression model identified long-term corticosteroid use (odds ratio [OR], 13.90; 95% confidence interval [CI], 1.27-151.7; P=.03) and the presence of >2 pacing leads versus 2 leads (OR, 5.41; 95% CI, 1.44-20.29; P=.01) as independent risk factors for PPM infection. In contrast, use of antibiotic prophylaxis prior to PPM implantation had a protective effect (OR, 0.087; 95% CI, 0.016-0.48; P=.005).Conclusions. These findings should assist clinicians in identifying patients who are at increased risk of PPM infection, as well as in developing strategies to minimize the modifiable risks.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578774     DOI: 10.1086/518889

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  59 in total

1.  The prevalence of methicillin resistant organisms among pacemaker and defibrillator implant recipients.

Authors:  David J Rodriguez; Aisha Afzal; Rudolph Evonich; David E Haines
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

2.  Complete removal of infected devices and simultaneous implantation of new devices for infective endocarditis after pacemaker implantation.

Authors:  Takuya Miura; Kazushige Inoue; Takenori Yokota; Takashi Iwata; Masao Yoshitatsu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-07-31

3.  A meta-analysis of antibacterial envelope use in prevention of cardiovascular implantable electronic device infection.

Authors:  Sajid Ali; Yousuf Kanjwal; Steven R Bruhl; Mohammed Alo; Mohammed Taleb; Syed S Ali; Ameer Kabour; Owais Khawaja
Journal:  Ther Adv Infect Dis       Date:  2017-05-01

4.  Management of infections involving implanted cardiac electrophysiologic devices.

Authors:  Frédéric L Paulin; Lorne J Gula; Raymond Yee; Allan C Skanes; George J Klein; Andrew D Krahn
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

5.  Cardiovascular implantable device infections.

Authors:  George M Viola; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

Review 6.  [Leadless endocardial ultrasound based left ventricular stimulation : WISE CRT System: alternative to conventional methods].

Authors:  C Butter; S Fehrendt; V Möller; M Seifert
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-11-08

7.  Efficacy of postoperative prophylactic antibiotics in reducing permanent pacemaker infections.

Authors:  Wen-Huang Lee; Ting-Chun Huang; Li-Jen Lin; Po-Tseng Lee; Chih-Chan Lin; Cheng-Han Lee; Ting-Hsing Chao; Yi-Heng Li; Ju-Yi Chen
Journal:  Clin Cardiol       Date:  2017-04-26       Impact factor: 2.882

8.  New Insights into Predictors of Cardiac Implantable Electronic Device Infection.

Authors:  Hossein Sadeghi; Abolfath Alizadehdiz; Amirfarjam Fazelifar; Zahra Emkanjoo; Majid Haghjoo
Journal:  Tex Heart Inst J       Date:  2018-06-01

9.  Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients.

Authors:  Matthew J Kolek; William F Dresen; Quinn S Wells; Christopher R Ellis
Journal:  Pacing Clin Electrophysiol       Date:  2012-12-17       Impact factor: 1.976

10.  New perspectives of infections in cardiovascular disease.

Authors:  Ignatius W Fong
Journal:  Curr Cardiol Rev       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.